rs629426

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_181514.2(MRPL21):​c.88+87T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.304 in 1,360,118 control chromosomes in the GnomAD database, including 66,725 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5788 hom., cov: 34)
Exomes 𝑓: 0.31 ( 60937 hom. )

Consequence

MRPL21
NM_181514.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.559

Publications

34 publications found
Variant links:
Genes affected
MRPL21 (HGNC:14479): (mitochondrial ribosomal protein L21) Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Multiple transcript variants encoding different isoforms were identified through sequence analysis although some may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Jul 2008]
IGHMBP2 (HGNC:5542): (immunoglobulin mu DNA binding protein 2) This gene encodes a helicase superfamily member that binds a specific DNA sequence from the immunoglobulin mu chain switch region. Mutations in this gene lead to spinal muscle atrophy with respiratory distress type 1. [provided by RefSeq, Jul 2008]
IGHMBP2 Gene-Disease associations (from GenCC):
  • autosomal recessive distal spinal muscular atrophy 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease axonal type 2S
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary peripheral neuropathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 11-68903636-A-G is Benign according to our data. Variant chr11-68903636-A-G is described in ClinVar as [Benign]. Clinvar id is 668907.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.462 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MRPL21NM_181514.2 linkc.88+87T>C intron_variant Intron 1 of 6 ENST00000362034.7 NP_852615.1 Q7Z2W9-1
MRPL21NM_181515.2 linkc.-181+87T>C intron_variant Intron 1 of 6 NP_852616.1 Q7Z2W9-2A0A024R5G7
MRPL21XM_005273823.5 linkc.88+87T>C intron_variant Intron 1 of 5 XP_005273880.1 B4DXI4
MRPL21XR_247190.5 linkn.110+87T>C intron_variant Intron 1 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MRPL21ENST00000362034.7 linkc.88+87T>C intron_variant Intron 1 of 6 1 NM_181514.2 ENSP00000354580.2 Q7Z2W9-1

Frequencies

GnomAD3 genomes
AF:
0.263
AC:
40042
AN:
152140
Hom.:
5791
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.182
Gnomad AMI
AF:
0.153
Gnomad AMR
AF:
0.179
Gnomad ASJ
AF:
0.370
Gnomad EAS
AF:
0.210
Gnomad SAS
AF:
0.478
Gnomad FIN
AF:
0.366
Gnomad MID
AF:
0.360
Gnomad NFE
AF:
0.300
Gnomad OTH
AF:
0.245
GnomAD4 exome
AF:
0.309
AC:
373483
AN:
1207858
Hom.:
60937
AF XY:
0.317
AC XY:
193084
AN XY:
608698
show subpopulations
African (AFR)
AF:
0.182
AC:
5189
AN:
28478
American (AMR)
AF:
0.132
AC:
5574
AN:
42226
Ashkenazi Jewish (ASJ)
AF:
0.359
AC:
8492
AN:
23668
East Asian (EAS)
AF:
0.244
AC:
9324
AN:
38186
South Asian (SAS)
AF:
0.484
AC:
39164
AN:
80894
European-Finnish (FIN)
AF:
0.375
AC:
18884
AN:
50380
Middle Eastern (MID)
AF:
0.350
AC:
1706
AN:
4868
European-Non Finnish (NFE)
AF:
0.304
AC:
269530
AN:
887402
Other (OTH)
AF:
0.302
AC:
15620
AN:
51756
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
12569
25138
37707
50276
62845
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8090
16180
24270
32360
40450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.263
AC:
40053
AN:
152260
Hom.:
5788
Cov.:
34
AF XY:
0.268
AC XY:
19976
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.182
AC:
7565
AN:
41558
American (AMR)
AF:
0.179
AC:
2738
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.370
AC:
1283
AN:
3470
East Asian (EAS)
AF:
0.210
AC:
1086
AN:
5168
South Asian (SAS)
AF:
0.478
AC:
2310
AN:
4830
European-Finnish (FIN)
AF:
0.366
AC:
3875
AN:
10598
Middle Eastern (MID)
AF:
0.371
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
0.300
AC:
20434
AN:
68014
Other (OTH)
AF:
0.243
AC:
514
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1559
3119
4678
6238
7797
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
430
860
1290
1720
2150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.286
Hom.:
17725
Bravo
AF:
0.240
Asia WGS
AF:
0.327
AC:
1133
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
8.9
DANN
Benign
0.83
PhyloP100
-0.56
PromoterAI
0.059
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs629426; hg19: chr11-68671104; COSMIC: COSV54821997; COSMIC: COSV54821997; API